News
TELCOR is excited to share industry news and updates with our stakeholders across the country.

FDA Will Not Extend Comment Period for Laboratory-Developed Tests Proposed Rule
The U.S. Food and Drug Administration announced Oct. 30 that it will not extend the standard 60-day comment period for its proposed rule on laboratory-developed tests (LDTs). “After considering the [...]
Senate Finance Committee Passes Health Extenders Legislation
On Nov. 8, the Senate Finance Committee passed the Better Mental Health Care, Lower Drug Cost, and Extenders Act, which was reported out of committee 26 to 0. Among other [...]
CMS Releases Final Physician Fee Schedule for Calendar Year 2024
The Centers for Medicare & Medicaid Services (CMS) released the 2024 final Physician Fee Schedule (PFS) on Nov. 2. Overall payment rates in the PFS will decrease by 1.25 percent [...]
Federal Agencies Release Fact Sheet on No Surprises Act Independent Dispute Resolution Process Proposed Rule
The Departments of Health and Human Services, Labor, and the Treasury and the Office of Personnel Management released a fact sheet on Oct. 27 detailing the No Surprises Act (NSA) [...]
UPDATE: House Energy and Commerce Subcommittee on Health Holds Legislative Hearing
On Oct. 19, the House Energy and Commerce Subcommittee on Health held a hearing to examine physician payment policies and proposed legislative solutions to increase beneficiary access to care. The [...]
House to Hold Legislative Subcommittee Hearing on SALSA and Other Medicare Payment Proposals
The House Energy and Commerce Subcommittee on Health will hold a legislative hearing on Thursday, Oct. 19, to examine proposals for fine-tuning Medicare payments. Among the legislation to be discussed [...]
Congressional Leaders Investigating Medicaid MCO Prior Authorization Denials
Senate Finance Committee Chair Ron Wyden (D-Ore.) and House Energy and Commerce Committee Ranking Member Frank Pallone, Jr. (D-N.J.) sent a series of letters on Oct. 3 to several Medicaid [...]
FDA Proposes Changes for Regulation of Laboratory-Developed Tests
The U.S. Food and Drug Administration has proposed a new rule seeking to amend FDA regulations to identify laboratory-developed tests (LDTs), or in vitro diagnostic products (IVDs) produced within a [...]
CAP and Others Express Concerns About MACs’ Genetic Testing Proposal for Oncology LCDs
Forty-five health care organizations recently cosigned a letter urging Novitas and First Coast Service Options (FCSO) to address concerns about their recently proposed local coverage determination (LCD) framework for genetic [...]
CMS Withdraws NCCI PTP Edits Issued for Presumptive and Definitive Tests
The Centers for Medicare & Medicaid Services is withdrawing National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) edits implemented on July 1, 2023, the agency announced Sept. 14. The NCCI PTP [...]